brodalumab

This page shows the latest brodalumab news and features for those working in and with pharma, biotech and healthcare.

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

However, Bausch Health still retains the rights to develop and market brodalumab within the US and Canada. ... Leo Pharma has had approval for brodalumab in the EU, which it markets under the name Kyntheum, since 2017.

Latest news

Novartis claims first place for psoriasis drug Cosentyx in China

It’s the first drug in the IL-17 inhibitor class to be approved in China, ahead of Eli Lilly’s Taltz (ixekizumab) and Bausch Health’s Siliq (brodalumab), and also
Sun Pharma passes milestone with novel psoriasis drug approval

IL-23-selective follow-up Tremfya (guselkumab) as well as three IL-17 inhibitors - Novartis’ Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) and Valeant Pharma’s Siliq (brodalumab).
AbbVie reports more solid data for would-be psoriasis blockbuster

ixekizumab) and Valeant’s Siliq (brodalumab).
Lilly claims another EU okay for Taltz

leader. A third IL-17 drug - Valeant’s Siliq (brodalumab) - was launched in the third quarter in the US at a discount to Cosentyx and Taltz but the company has yet
European Commission backs LEO Pharma’s Kyntheum

Novel biologic therapies such as brodalumab mean that achieving completely clear skin can now be a reality for people with moderate-to-severe psoriasis.”. ... Additionally, across all three trials, 56-61% of patients reported the skin condition no

More from news
Approximately 10 fully matching, plus 33 partially matching documents found.

Latest Intelligence

Pharma deals in September 2015

Brodalumab is phase III complete, but is thought to have been cast off due to concerns raised over links to the drug and suicidal thoughts. ... Collaboration - discovery. 500. AstraZeneca. Valeant Pharmaceuticals. Brodalumab for psoriasis, ready for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Account Director – UK Office: Excellent salary and benefits

Account Director, Healthcare Communications: Salary TBC

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Subscribe to our email news alerts

PMHub

Add my company

Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...